• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY, INC. ORBERA365 INTRAGASTRIC BALLOON SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY, INC. ORBERA365 INTRAGASTRIC BALLOON SYSTEM Back to Search Results
Model Number B-50012
Device Problem Fluid/Blood Leak (1250)
Patient Problem Vomiting (2144)
Event Date 11/19/2018
Event Type  malfunction  
Manufacturer Narrative
Additional information regarding this late medwatch report: during a february 2019 internal review of post-market surveillance data for all apollo products, apollo executive management was made aware that complaints associated with the ce marked orbera365 (12-month intragastric balloon) were not being assessed for reportability consistent with the requirements of 21 cfr 803.Consideration for reportability in the us was incorrectly established based on the difference in the indications for use (i.E.12-month placement vs 6-month placement) vs considerations for 'similar devices' marketed by apollo.The orbera365 12-month intragastric balloon is a [?]similar device' as compared to the orbera 6-month balloon approved via pma p140008, and as such, complaints will be assessed for mdr reportability going forward.Device evaluation summary: the device was returned to apollo, and a visual inspection was performed.The balloon shell was noted to be discolored, as it was brown in appearance.Green particles were noted to be covering approximately 80% of the outer surface of the balloon shell.White particulate matter was noted on the outer surface of the balloon shell and center patch.The center patch was noted to be discolored, as it was yellow in appearance.A valve test was performed, and when di water was injected into the balloon valve, the flow of fluid was continuous and unobstructed.An air leak test was performed, and leakage was noted form the large tear on the anterior portion of the balloon shell.Under microscopic analysis, the apparent origination point of the tear was noted to have striated edges, consistent with damage from a surgical tool.Brown particulate matter was noted on the inner surface of the valve channel.A review of device labeling notes the following: warnings and precautions: the risk of balloon deflation and intestinal obstruction (and therefore possible death related to intestinal obstruction) may be higher when balloons are left in place longer than 12 months or used at larger volumes (greater than 700 cc).The physiological response of the patient to the presence of the orbera365¿ system balloon may vary depending upon the patient's general condition and the level and type of activity.The types and frequency of administration of drugs or diet supplements and the overall diet of the patient may also affect the response.Each patient must be monitored closely during the entire term of treatment in order to detect the development of possible complications.Each patient should be instructed regarding symptoms of deflation, gastrointestinal obstruction, acute pancreatitis, spontaneous inflation, ulceration and other complications which might occur, and should be advised to contact his/her physician immediately upon the onset of such symptoms.Complications- possible complications of the use of the orbera365¿ system include: balloon deflation and subsequent replacement.
 
Event Description
Reported as: a patient with the orbera 365 intragastric balloon had "suddenly throws up the balloon, after having the orbera 365 implanted for approx.10 months without any problem.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORBERA365 INTRAGASTRIC BALLOON SYSTEM
Type of Device
INTRAGASTRIC BALLOON
Manufacturer (Section D)
APOLLO ENDOSURGERY, INC.
1120 s. capital of texas hwy
bldg 1, ste. 300
austin TX 78746
Manufacturer (Section G)
APOLLO ENDOSURGERY COSTA RICA, SRL
coyol free zone
building b 13.3
alajuela,
CS  
Manufacturer Contact
tracy whisman
1120 s. capital of texas hwy
bldg 1, ste. 300
austin, TX 78746
MDR Report Key9100111
MDR Text Key159699764
Report Number3006722112-2019-00089
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
Reporter Country CodeDA
PMA/PMN Number
P140008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 12/04/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/12/2019
Device Model NumberB-50012
Device Catalogue NumberB-50012
Device Lot NumberAF01245
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/07/2019
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/04/2018
Initial Date FDA Received09/20/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/12/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-